MedTrace Logo

Newborn Screening for Severe Combined Immunodeficiency (SCID) in a High-Risk Population

NCT00845416 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1800

Last updated 2012-07-16

No results posted yet for this study

Summary

The goal of the proposed research is to establish the validity of a newborn screening method for severe combined immunodeficiency (SCID). The assay to be used is developed on the basis of PCR quantification of T-cell receptor excision circles (TRECs) that is absent in SCID patients, thus correlating with the disease

Conditions

  • Severe Combined Immunodeficiency
  • T Cell Lymphocytopenia

Sponsors & Collaborators

Eligibility

Min Age
1 Day
Max Age
30 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-03-31
Primary Completion
2011-11-30
Completion
2011-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00845416 on ClinicalTrials.gov